Medicinova, Inc.

$1.330
USD
Last updated on --.
24h volume1.08K
24h highest1.3300 USD
24h lowest1.3100 USD
24h Price movement+0.76%

MNOV recent prices

24 Hours
+0.76%+$0.01
30 days
-6.03%-$0.085
60 days
-6.03%-$0.085
90 days
-2.57%-$0.035

Key data

Previous close1.3200 USD
Market cap66.94M USD
Volume1.08K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.24000 USD
Net income (FY)-11.72M USD
Revenue (FY)596.64K USD
Last report dateMay 14, 2026

About Medicinova, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersLA JOLLA
Employees (FY)6.00
Revenue per employee (FY)99.44K USD
Net income per employee (FY)-1.95M USD
Listed onNasdaq
Official website

MNOV conversion tables

MNOVMNOV
USDUSD
0.5 MNOV0.665 USD
1 MNOV1.330 USD
5 MNOV6.650 USD
10 MNOV13.3 USD
USDUSD
MNOVMNOV
0.5 USD0.37594 MNOV
1 USD0.75188 MNOV
5 USD3.759 MNOV
10 USD7.518 MNOV

FAQ

MNOV is trading at $1.330, +0.76% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MNOV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MNOV is currently trading at $1.330, +0.76% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MNOV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MNOV's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MNOV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MNOV's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Medicinova, Inc.'s market cap is currently 66.94M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.08K
24h highest1.3300 USD
24h lowest1.3100 USD
24h Price movement+0.76%
MNOVMNOV
USDUSD
Start trade with MNOV Perpetual